1. Unsustainalble manufacturing practices, that is why schedule M of drugs and comsetics act 1940, ask manufacturers to deploy best manufatcuring practices in pharmaceutical industry
2.high regulatory costs involved due to guidelines by regulatory bodies (over regulation), National pricing and pharmaceutical authority issues guidleines on the medicines to be inducted into national list of essential medicines, in that case, the price is also fixed by them for these medicines. So many producers of such drugs suffer loss.
3. NPPA also regulates non essential medicines, in such case it has given rise to pressur groups, to pressurise the government to bring down the costs of such medincines
4. generic medicines are not accepted by many people due to risks (they fear). Howver,t here are little evidences of anything going wrong due to generic medicines. this send wrong signal to the world and experts fear india will lose "pharmacy of the world' tag (howver USA recently forumlates atask force to come up with generic medicines on account of high costs of brnaded medicines ), such examples do favour right generic medicine policy of the government.
5. ethical issues involved in the clinical trials, many deaths caused due to the vaccine proposed which is cmpletely indigeneous, also somewhere affect the ambition of India being called 'pharmacy to the world'
2.high regulatory costs involved due to guidelines by regulatory bodies (over regulation), National pricing and pharmaceutical authority issues guidleines on the medicines to be inducted into national list of essential medicines, in that case, the price is also fixed by them for these medicines. So many producers of such drugs suffer loss.
3. NPPA also regulates non essential medicines, in such case it has given rise to pressur groups, to pressurise the government to bring down the costs of such medincines
4. generic medicines are not accepted by many people due to risks (they fear). Howver,t here are little evidences of anything going wrong due to generic medicines. this send wrong signal to the world and experts fear india will lose "pharmacy of the world' tag (howver USA recently forumlates atask force to come up with generic medicines on account of high costs of brnaded medicines ), such examples do favour right generic medicine policy of the government.
5. ethical issues involved in the clinical trials, many deaths caused due to the vaccine proposed which is cmpletely indigeneous, also somewhere affect the ambition of India being called 'pharmacy to the world'